Because AMPK functions as a tumor suppressor by inhibiting the mTOR pathway [53], we hypothesized that the decreased PRKAG3 activity in mammary carcinoma may decrease the inhibitory effect of AMPK, leading to tumor growth. Here, MTOR is linked to neoplasm.